HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuyuki Uchida Selected Research

Formaldehyde (Formol)

1/2022Nodal T-zone lymphoma and T-zone hyperplasia in dogs.
3/2021ErbB2 copy number gain is associated with adverse outcome in canine mammary carcinoma.
11/2020Immunophenotyping of Nonneoplastic and Neoplastic Histiocytes in Cats and Characterization of a Novel Cell Line Derived From Feline Progressive Histiocytosis.
11/2017Immunohistochemical analysis of canine and feline muscle disorders using formalin-fixed, paraffin-embedded tissues.
2/2012Retrobulbar primitive neuroectodermal tumor in a squirrel monkey (Saimiri sciureus).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuyuki Uchida Research Topics

Disease

71Neoplasms (Cancer)
04/2024 - 10/2003
15Inflammation (Inflammations)
11/2022 - 10/2012
14Alzheimer Disease (Alzheimer's Disease)
12/2023 - 01/2012
13Lymphoma (Lymphomas)
12/2023 - 12/2009
12Carcinoma (Carcinomatosis)
12/2023 - 06/2012
9Cognitive Dysfunction
08/2023 - 01/2017
8Amyloid Plaque
12/2023 - 01/2012
8Polyps
01/2018 - 01/2012
7Neurodegenerative Diseases (Neurodegenerative Disease)
08/2023 - 01/2017
7Dementia (Dementias)
08/2023 - 01/2017
6Meningioma (Meningiomas)
10/2023 - 12/2007
6Adenocarcinoma
09/2020 - 12/2014
5Oligodendroglioma
04/2024 - 11/2012
5T-Cell Lymphoma (Lymphoma, T Cell)
12/2023 - 11/2021
5Carcinogenesis
11/2023 - 09/2019
5Tauopathies
08/2023 - 10/2018
5Cysts
01/2019 - 05/2012
5Parkinson Disease (Parkinson's Disease)
10/2018 - 01/2013
4Glioma (Gliomas)
04/2024 - 01/2013
4Muscular Dystrophies (Muscular Dystrophy)
02/2024 - 07/2008
4Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2024 - 09/2021
4Papilloma (Papillomatosis)
11/2021 - 03/2018
4Histiocytic Sarcoma
08/2021 - 12/2003
4Neuroaxonal Dystrophies (Neuroaxonal Dystrophy, Late Infantile)
12/2017 - 10/2007
4Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
08/2014 - 12/2011
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2023 - 03/2018
3Retinoblastoma (Glioblastoma, Retinal)
11/2023 - 02/2012
3Adenoma (Adenomas)
03/2021 - 01/2018
3Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
01/2021 - 01/2012
3Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 01/2018
3Hyperplasia
01/2020 - 05/2012
3Neoplasm Metastasis (Metastasis)
07/2019 - 06/2012
3Atrophy
11/2017 - 11/2004
3Lysosomal Storage Diseases (Lysosomal Storage Disease)
03/2016 - 07/2011
3Porcine Reproductive and Respiratory Syndrome (PRRS)
04/2015 - 05/2014
3Infections
06/2013 - 02/2004
3Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis)
01/2013 - 11/2010
3Ischemia
10/2009 - 09/2008
2Tuberculosis (Tuberculoses)
01/2024 - 03/2007
2Neuroendocrine Carcinoma
01/2024 - 06/2014
2Astrocytoma (Pilocytic Astrocytoma)
01/2024 - 01/2013
2Melanoma (Melanoma, Malignant)
11/2023 - 11/2020
2Lymphocytosis
10/2023 - 01/2022
2Inborn Genetic Diseases (Disease, Hereditary)
05/2023 - 03/2019
2Necrosis
04/2022 - 05/2019
2Wilms Tumor (Wilm's Tumor)
03/2022 - 01/2018

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
01/2024 - 09/2008
16Amyloid (Amyloid Fibrils)IBA
12/2023 - 04/2012
11Keratins (Keratin)IBA
07/2023 - 08/2011
8DNA (Deoxyribonucleic Acid)IBA
01/2023 - 02/2018
7TubulinIBA
01/2024 - 09/2010
7AntigensIBA
01/2024 - 04/2015
7Messenger RNA (mRNA)IBA
12/2023 - 10/2012
6MucinsIBA
12/2023 - 07/2018
5DystrophinIBA
02/2024 - 11/2017
5SynaptophysinIBA
01/2024 - 07/2016
5CytokinesIBA
10/2023 - 05/2014
5Peptides (Polypeptides)IBA
08/2023 - 12/2018
5Cadherins (E-Cadherin)IBA
11/2022 - 06/2014
5ParaffinIBA
01/2022 - 03/2016
5Formaldehyde (Formol)FDA Link
01/2022 - 02/2012
5VimentinIBA
08/2021 - 02/2012
5AcidsIBA
11/2020 - 01/2017
4NestinIBA
01/2024 - 02/2012
4Granzymes (Granzyme)IBA
12/2023 - 11/2021
4CateninsIBA
11/2022 - 01/2021
4LipidsIBA
01/2021 - 06/2008
4human ERBB2 proteinIBA
06/2020 - 01/2019
4Prednisolone (Predate)FDA LinkGeneric
07/2019 - 08/2009
4NAD (NADH)IBA
12/2017 - 10/2007
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2023 - 01/2012
3tau Proteins (tau Protein)IBA
12/2023 - 01/2012
3DipeptidesIBA
08/2023 - 01/2019
3Tryptophan (L-Tryptophan)FDA Link
08/2023 - 01/2019
3Cell Adhesion MoleculesIBA
11/2022 - 02/2015
3Periodic AcidIBA
11/2021 - 06/2017
3Alcian BlueIBA
11/2021 - 10/2006
3SynucleinsIBA
10/2021 - 10/2018
3DesminIBA
09/2021 - 10/2003
3AutoantibodiesIBA
05/2019 - 03/2004
3Glial Fibrillary Acidic ProteinIBA
01/2019 - 02/2012
3CalciumIBA
02/2018 - 01/2011
3Antigen Receptors (Antigen Receptor)IBA
06/2016 - 12/2009
3Muramidase (Lysozyme)IBA
05/2016 - 12/2003
3Pattern Recognition ReceptorsIBA
04/2015 - 05/2014
2Platelet-Derived Growth FactorIBA
04/2024 - 10/2023
2Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
04/2024 - 01/2018
2GastrinsIBA
01/2024 - 06/2014
2Adrenocorticotropic Hormone (ACTH)FDA Link
11/2023 - 01/2019
25- (benzoylamino)- N- (4- chlorophenyl)- 3- methyl- 4- isothiazolecarboxamide (ITCL)IBA
10/2023 - 01/2022
2Tyrosine (L-Tyrosine)FDA Link
08/2023 - 06/2019
2CholesterolIBA
05/2023 - 09/2008
2LipopolysaccharidesIBA
11/2022 - 01/2019
2CollagenIBA
06/2022 - 03/2015
2Progesterone Receptors (Progesterone Receptor)IBA
03/2022 - 01/2018
2Asparaginase (Elspar)FDA Link
03/2022 - 07/2019

Therapy/Procedure

13Therapeutics
06/2023 - 04/2011
10Drug Therapy (Chemotherapy)
05/2021 - 02/2004
3Immunotherapy
06/2023 - 01/2021
3Radiotherapy
12/2014 - 11/2012